Expert view: Measuring protein interactions in blood – not as trivial as it sounds
Posted: 11 September 2020 | Fluidic Analytics | No comments yet
In the continuing battle against COVID-19, researchers now must identify the best candidates for vaccines and convalescent serum therapies against the virus.
This is more difficult than it sounds and will require researchers to employ new techniques that are not based on decades-old technologies. At the heart of this challenge is the accurate identification of neutralising antibodies – proteins that bind to the SARS-CoV-2 spike protein, thereby halting entry of the virus into cells.
Related topics
Analytical techniques, Antibodies, Immunoassays, Research & Development
Related organisations
Fluidic Analytics